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Abstract
Thiazide-like diuretics are the most commonly used drugs to treat arterial hypertension, with their efficacy being linked to their chronic 
vasodilatory effect. Previous studies suggest that activation of the large conductance voltage- and Ca2+-dependent K+ (BK) channel (Slo 
1, MaxiK channel) is responsible for the thiazide-induced vasodilatory effect. But the direct electrophysiological evidence supporting 
this claim is lacking. BK channels can be associated with one small accessory β-subunit (β1–β4) that confers specific biophysical and 
pharmacological characteristics to the current phenotype. The β1-subunit is primarily expressed in smooth muscle cells (SMCs). In 
this study we investigated the effect of hydrochlorothiazide (HCTZ) on BK channel activity in native SMCs from human umbilical artery 
(HUASMCs) and HEK293T cells expressing the BK channel (with and without the β1-subunit). Bath application of HCTZ (10 µmol/L) 
significantly augmented the BK current in HUASMCs when recorded using the whole-cell configurations, but it did not affect the unitary 
conductance and open probability of the BK channel in HUASMCs evaluated in the inside-out configuration, suggesting an indirect 
mechanism requiring cell integrity. In HEK293T cells expressing BK channels, HCTZ-augmented BK channel activity was only observed 
when the β1-subunit was co-expressed, being concentration-dependent with an EC50 of 28.4 µmol/L, whereas membrane potential did 
not influence the concentration relationship. Moreover, HCTZ did not affect the BK channel current in HEK293T cells evaluated in the 
inside-out configuration, but significantly increases the open probability in the cell-attached configuration. Our data demonstrate that a 
β1-subunit-dependent mechanism that requires SMC integrity leads to HCTZ-induced BK channel activation.
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Introduction
Thiazide diuretics remain as one  of the drugs most commonly 
used to treat systemic arterial hypertension.  In particular, 
hydrochlorothiazide (HCTZ) is one of the first-line antihy-
pertensive therapy drugs[1].  HCTZ and related agents exert 
antihypertensive effects by primarily acting on the kidney, 
where these drugs block the Na+/Cl- cotransporter (NCC) and 
thus produce acute diuresis[2].  However, long-term antihyper-
tensive therapy with thiazides has been linked to the agents’ 
ability to lower vascular resistance rather than to their diuretic 
action[2, 3].  Remarkably, despite 58 years of demonstrated anti-
hypertensive effectiveness, the precise mechanism(s) by which 
HCTZ and related thiazides evoke vasodilation and therefore 
reduce vascular resistance are not fully characterized.
Thiazide-induced vasorelaxation has been well documented 
through in vivo and ex vivo experiments in humans[4-6] and 
other species[5, 7-9].  Although studies have established that thi-
azide-induced vasodilation contributes to the clinical benefit 
of these agents in chronically treated hypertensive patients, 
several studies have shown that such thiazide action is inde-
pendent of NCC blockade[3, 10, 11].  Different mechanisms have 
been proposed to mediate thiazide-induced artery dilation by 
targeting smooth muscle cells, including activation of large 
conductance, voltage- and [Ca2+]i-gated potassium (BK) chan-
nels[4, 5, 7, 8, 12], inhibition of voltage-operated calcium channels 
(VOCCs)[5, 7, 8, 13] and/or inhibition of the RhoA/Rho kinase 
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pathway[9].  The latter would induce a Ca2+ desensitization of 
the smooth muscle contractile machinery.  Making the overall 
scenario more complex, it has been argued that the relative 
contribution of each of the proposed mechanisms to thiazide-
induced vasodilation depends on the species from which vas-
cular tissue was obtained for ex vivo assays[5].
The importance of BK channels in the regulation of vascular 
smooth muscle cell (VSMC) contractility, peripheral resistance 
and blood pressure has been extensively established[14, 15].  These 
channels are activated by  membrane depolarization and/or an 
increase in intracellular Ca2+ concentration.  Since both events 
are associated with VSMC contraction and BK channel activa-
tion, the evoked outward K+ current acts as a negative feedback 
mechanism on VSMC contraction, thereby favoring VSMC 
relaxation[15, 16].  Moreover, several studies have suggested that 
BK channel activity is altered in hypertension (see[17] and[18] 
reviews for more detail).  Thus, the activation of this ion channel 
has emerged as a novel molecular target for treating diseases 
where increased tone and/or contractility of smooth muscle 
play a relevant pathophysiological role, such as hypertension[19].
In most mammalian tissues, native BK channels are homotet-
ramers of pore-forming α-subunits (encoded by the KCNMA1 
gene, also named Slo1) that can be  associated with one of 
four auxiliary β-subunits (encoded by KCNMB1-4 genes)[20-25]. 
Unlike α-subunits, β-subunits do not form functional chan-
nels but modify several gating processes[26-28].  The differential 
expression of auxiliary subunits in different cell types explains 
the multiplicity of functions and regulatory mechanisms of 
BK channels.  In VSMCs, the β1-subunit is a main partner of 
the BK channel[25, 29].  Several studies have shown that endog-
enous and exogenous compounds can modulate BK chan-
nels through β-subunits[30-33].  Additionally, mutations in the 
β1-subunit that confer a gain in BK activity are associated with 
the reduced prevalence of hypertension in humans[34], and the 
opposite effect occurs in the case of a loss of function muta-
tion[35].
HCTZ did not activate BK channels in skeletal muscle and 
BK channel α-subunits expressed in HEK cells, two prepara-
tions in which the functional expression of BK β1 is negli-
gible[36, 37].  Moreover, the hypothesis that the activation of vas-
cular smooth muscle BK channels, which contain β1-subunits, 
is involved in HCTZ-induced vasodilation is supported by 
ex vivo experiments in which this effect is abolished in the 
presence of BK channel inhibitors[5, 8, 12].  The lack of electro-
physiological studies on VSMCs makes it difficult to establish 
whether HCTZ-induced BK activation reflects a direct drug 
interaction with channel subunits or indirect drug interactions, 
i.e., requiring additional cell signals.  This question requires 
electrophysiological studies on VSMCs using different patch-
clamp configurations under controlled conditions of voltage 
and [Ca2+]i.
In the present study, using patch-clamp electrophysiol-
ogy, we determined the effects of HCTZ on (i) BK channels 
from native human umbilical artery smooth muscle cells 
(HUASMCs) in “whole cell” (WCR) and cell-free, “inside-out” 
(IO) configurations and (ii) recombinant BK (slo1) channels 
with or without β1-subunits co-expressed in HEK293T cells. 
These results demonstrated that HCTZ effectively induces BK 
channel activation, and this effect requires both cell integrity 
and the presence of β1-subunits.
Materials and methods
Smooth muscle cell isolation for patch-clamp experiments
Umbilical cords were obtained from normal term pregnan-
cies after vaginal and cesarean deliveries.  The umbilical cords 
were placed in a transport solution with the following com-
position (in mmol/L): 130 NaCl, 4.7 KCl, 1.17 KH2PO4, 1.16 
MgSO4, 24 NaCO3H, and 2.5 CaCl2, pH 7.4 at 4 ºC.  The umbili-
cal cords were immediately transferred to the laboratory, 
stored at 4°C and used within the next 24 h.  All procedures 
were performed in accordance with the Declaration of Hel-
sinki (1975).
Human umbilical arteries (HUAs) were dissected from 
Wharton’s jelly just prior to cell isolation.  HUA smooth mus-
cle cells (HUASMCs) were isolated as previously described[38], 
with further modifications to diminish the enzyme content in 
the dissociation medium (DM)[32].  Briefly, a segment of HUA 
was cleaned of any residual connective tissue (Wharton’s jelly), 
cut into small strips and placed for 15 min in DM containing 
the following (in mmol/L): 140 NaCl, 5 KH2PO4, 5 MgCl2, 6 
glucose, and 5 HEPES; the pH was adjusted to 7.4 with NaOH. 
Vessel strips were subsequently placed in DM containing 3 
mg/mL collagenase type I for 15–30 min, with gentle agitation 
at 35 °C.  After the incubation period, the strips were washed 
with DM, and single HUASMCs were obtained by gentle 
aspiration of the tissue through a Pasteur pipette to render cell 
dispersion.  The supernatant containing the isolated cells was 
stored at room temperature (~22 °C) until further use.  Imme-
diately prior to electrophysiological recordings, HUASMCs 
were allowed to settle onto the coverglass bottom of a 3-mL 
experimental chamber.  Only well-relaxed, spindle-shaped 
smooth muscle cells were used for patch-clamp electrophysiol-
ogy.  Data were collected within 4–6 h after cell isolation.
Clones and transient transfection
HEK293T cells were grown in Dulbecco's modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) and subsequently split when reaching 70%–80% con-
fluence.  The pcDNA3 plasmids harboring the human Slo1 
α-subunit (A#U11058), the auxiliary β1-subunit (A#AF035046) 
and enhanced green fluorescent protein (eGFP) cDNAs 
were transfected into HEK cells using FuGene 6 (Promega 
, Madison, WI, USA) and transiently expressed.  Transfec-
tions were performed in HEK cells grown in 30-mm Petri 
dishes using cDNAs encoding the α-subunits alone or both 
α- and β1-subunits.  The α- and β1-subunits were mixed at 1:3 
molar ratios to ensure that all α-subunits were saturated with 
β1-subunits (total amount of DNA: 2.5 µg distributed in 0.5, 
0.7 and 1.3 µg of plasmids containing eGFP, α-subunits and 
β1-subunits, respectively).  When α-subunits were transfected 
alone, β1 cDNA was replaced with empty plasmid.  After 
transfection, the cells were cultured for 18 h.  The electro-
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physiological measurements were performed 18–24 h after 
transfection.  BK α and β1 clones were kind gifts of Dr Carlos 
GONZÁLEZ (CINV, Chile).  The eGFP clone and vector were 
kindly provided by Dr J RAINGO (IMBICE, Argentina).
Electrophysiology
Isolated cells were observed using a mechanically stabilized 
inverted epifluorescence microscope (Arcano XYL 403 YAT 
PLAN, China) equipped with a 40× objective lens.  Test solu-
tions were applied through a multibarreled pipette positioned 
close to the target cell (approximated 1 mm), which enabled 
bathing the cell or the pipette tip (in the inside-out configura-
tion) with the test solution for only 5 s.  The perfusion rate was 
approximately 1 mL/min.  After each experiment on a single 
cell, the experimental chamber was replaced with another 
containing a new sample of cells.  All experiments were per-
formed at room temperature (~22 °C).  For all experimental 
data included in the present study, we prolonged the exposure 
time to HCTZ to at least 15 min to ensure drug permeation, 
reflecting its poor lipophilicity.  The concentration-response 
curve to HCTZ (10–300 µmol/L) in HEK293T cells was con-
structed by applying a single HCTZ concentration to each 
cell since it took at least 15 min for HCTZ to increase channel 
activity.
The standard tight-seal IO and WCR configurations of the 
patch-clamp technique[39] were used to record single-channel 
and macroscopic currents, respectively.  Glass pipettes were 
pulled from WPI PG52165-4 glass on a two-stage vertical 
micropipette puller (PP-83, Narishige Scientific Instrument 
Laboratories, Tokyo, Japan).  Pipette resistance ranged from 
1.7 to 3.5 MΩ when filled with electrode solution.  All cur-
rents were filtered with a 4-pole low-pass Bessel filter at 2 kHz 
(Axopatch 200A amplifier, Axon Instruments, Foster City, CA, 
USA) and digitized (Digidata 1440, Molecular Devices, Sunny-
valle, CA, USA) at 20 kHz.  Recordings were stored on a com-
puter hard disk for subsequent analysis.
Single-channel recordings
Single-channel currents were recorded in the inside-out con-
figuration (IO) in HUASMCs and the cell-attached configura-
tion (CA) in HEK293T cells co-transfected with the α- and 
β1-subunits of the BK channel.  Voltage-clamp recordings (up 
to 30–60 s) were obtained at different membrane potentials to 
measure the single channel current amplitude and steady-state 
activity, which results from the product of the single channel 
open probability (Po) and the number of functional channels 
in the membrane patch (N).  Identification of BK channel pres-
ence in the patch was based on its unitary conductance value, 
voltage-dependent activity and activation by an increase in 
intracellular Ca2+ concentration, as previously described[40]. 
The control pipette solution used for single-channel recordings 
contained the following components (in mmol/L): 140 KCl, 0.5 
MgCl2, 10 HEPES, 6 glucose, and 1 CaCl2; the pH was adjusted 
to 7.4 with KOH.  The bath solution (BS) contained the follow-
ing components (in mmol/L): 140 KCl, 0.5 MgCl2, 0.4 CaCl2, 
10 HEPES, 6 glucose, and 1 EGTA; the pH was adjusted to 7.4 
with KOH.  The free Ca2+ concentration was calculated as 50 
nmol/L using Maxchelator software from Stanford University 
(http://maxchelator.stanford.edu).
HCTZ’s action on BK channels was examined by directly 
adding the adequate drug quantity to the BS to reach the 
desired final concentration.  Single-channel currents were 
analyzed using Clampfit software (Molecular Devices, version 
10.3).  Steady-state activity (NPo) was derived from the equa-






where T is the recording duration and tj is the time spent with 
j=1,2,3,…n channels open.  Stationary conditions of single 
channel recordings were controlled by plotting the NPo values 
calculated for intervals of 30 s of recording as a function of 
time (i.e., a stability plot).
Whole-cell recordings in HUASMCs
Whole-cell current stability was monitored by applying suc-
cessive 500 ms voltage steps, from a holding potential of -50 
mV to a test potential of +40 mV.  Thus, cells in which the 
current amplitude did not remain constant in time were dis-
carded.  After the current was stabilized, the same voltage-
clamp step protocol was applied under control (solvent) 
conditions or in the presence of HCTZ.  A voltage-clamp 
step protocol, including 500 ms voltage steps spaced 10 mV 
between -70 and +70 mV from a holding potential of -50 mV, 
was applied under control conditions and in the presence of 
HCTZ for further current amplitude-voltage relationship (I-V) 
analysis.  The pipette solution contained the following compo-
nents (in mmol/L): 130 KCl, 10 HEPES, 0.1 EGTA, 0.1 CaCl2, 1 
MgCl2, and 5 ATP-Na2; the pH was adjusted to 7.4 with KOH. 
The BS contained the following components (in mmol/L): 130 
NaCl, 5.4 KCl, 1.2 MgCl2, 2.5 CaCl2, 5 HEPES, 6 glucose, and 
5 4-aminopirydine (4-AP); the pH was adjusted to 7.4 with 
HCl.  The compound 4-AP was added to block Kv channels, 
which have been detected in HUASMCs[41].  Cell membrane 
capacitance was calculated from the capacity current obtained 
from the recording of a single 6-ms voltage step from a hold-
ing potential of -50 mV to -60 mV.  The mean capacitance and 
series resistance of the recorded HUASMCs were 24.8±2.0 pF 
and 3.1±0.3 MΩ, respectively.  
Inside-Out macroscopic current recordings in heterologously 
expressed BK channels
Macroscopic currents of recombinant BK channels expressed 
in HEK293T cells were recorded using the IO configuration. 
Current stability was monitored by applying successive 150 
ms voltage steps (from a holding potential of 0 mV to a test 
potential of +90 mV).  Cells in which the current amplitude 
did not remain constant in time were discarded.  The same 
voltage-clamp step protocol was applied under control condi-
tions and in the presence of HCTZ.  After current stabilization, 
a voltage-clamp step protocol, including a family of 150 ms 
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voltage steps spaced 20 mV between -90 and 190 mV from a 
holding potential of 0 mV followed by a 50 ms voltage step 
to -150 mV, was applied under control conditions and in the 
presence of 10, 30 and 100 µmol/L HCTZ for I-V relation-
ship analysis.  Since channel expression (estimated by current 
amplitude) was extremely variable and the current saturated 
the amplifier at the more positive potentials examined in most 
of the evaluated cells, the current values were normalized to 
the control current obtained at +130 mV.  The pipette and bath 
solutions were identical to those used in the IO experiments in 
HUASMCs.  
Whole-cell current recordings in heterologously expressed BKCa 
channels
The effects of HCTZ on whole-cell currents mediated by 
BK channel-forming slo1 proteins (α-subunit) expressed in 
HEK293T cells with and without the β1-subunit were exam-
ined.  Current stability was monitored by applying successive 
100 ms voltage steps (from a holding potential of -50 mV to 
a test potential of +60 mV), discarding cells in which the cur-
rent amplitude did not remain constant in time.  The same 
voltage-clamp step protocol was applied under control condi-
tions or in the presence of HCTZ.  After current stabilization, 
a voltage-clamp step protocol, including a family of 100 ms 
voltage steps spaced 10 mV between -60 and +90 mV from a 
holding potential of -50 mV, was applied under control condi-
tions and in the presence of 10, 30, 100 and 300 µmol/L HCTZ 
to conduct I-V plots.  Since channel expression was extremely 
variable and the current saturated the amplifier at the more 
positive potentials examined in most of the evaluated cells, 
current values were normalized to the control values obtained 
at +90 mV.  The pipette solution contained the following com-
ponents (in mmol/L): 130 KCl, 10 HEPES, 1 EGTA, 0.4 CaCl2, 1 
MgCl2, and 5 ATP-Na2; the pH was adjusted to 7.3 with KOH. 
The BS contained the following components (in mmol/L): 130 
NaCl, 5.4 KCl, 1 EGTA, 1.2 MgCl2, 0.0094 CaCl2, 5 HEPES, and 
6 glucose; the pH was adjusted to 7.4 with NaOH.  Both solu-
tions contained a nominal free Ca2+ concentration of 50 nmol/
L, calculated using Maxchelator.  The mean series resistance of 
the recorded HEK293T cells was 2.7±0.2 MΩ.
Drugs and reagents used
HCTZ, 4-AP, EGTA, Na2ATP and collagenase were purchased 
from Sigma Chemical Co (St Louis, USA).  All other reagents, 
including DMEM medium and FBS, were of analytical grade 
and purchased from local suppliers.  HCTZ was dissolved in 
dimethyl sulfoxide (DMSO).  Fresh aliquots of stock solutions 
of HCTZ in DMSO were added to the bath solution on the 
day of the experiment.  Appropriate amounts of DMSO were 
added to all control solutions without HCTZ.
Statistics
The results are expressed as the means±standard error of the 
mean.  Paired Student’s t tests were used to compare two 
groups.  ANOVA was used to compare more than two groups. 
In all cases, a P value less than 0.05 was considered as statisti-
cally significant.  The concentration-response curve data for 
BK channel activation by HCTZ were fitted using GraphPad 
Prism (version 5.03) to a Hill relationship with a variable 
slope.  The equation used for this fit is:
Current increase = Bottom +
1+10((logEC50–x)×Hill slope)
Top – Bottom
where EC50 is the concentration of agonist that gives a response 
halfway between bottom and top, Hill slope describes the 
steepness of the curves, and top and bottom are plateaus of 
current increase.  In the present study, we used the parameter 
pD2, which is the –log EC50.  The fitting parameters at different 
voltages were compared using the extra sum of squares prin-
ciple (F method available in GraphPad Prism).  
Results
Hydrochlorothiazide activates whole-cell BK current in human 
umbilical artery smooth muscle cells (HUASMCs)
Based on the ex vivo results from Calder et al[8, 12] and Pickkers 
et al[4, 7], BK channel activation was postulated as the mechanism 
underlying vasodilation mediated by thiazide-like diuretics. 
However, the effect of HCTZ on the BK currents from native 
vascular smooth muscle cells has not actually been evaluated. 
Furthermore, when this diuretic was tested on skeletal muscle 
cells and HEK cells expressing the α-subunit of this chan-
nel[36, 37], it failed to activate BK channels in both native and 
heterologous systems in the absence of any β-subunit.  Thus, 
we evaluated the effect of HCTZ in freshly dissociated 
HUASMCs as a model of human VSMCs in which the BK 
channel is associated with the β1-subunit[32] and involved in 
the regulation of the basal tone[42].  We obtained the isolated 
voltage-activated macroscopic BK currents from HUASMCs 
in the standard patch-clamp WCR configuration as previously 
described [32, 42] and examined the effect of HCTZ on these cells 
(Figure 1).  The data demonstrated that after 7 min of bath 
(extracellular) application of 10 µmol/L HCTZ, the amplitude 
of the outward whole-cell current was significantly augmented 
at membrane potential values between 20 and 70 mV (Figure 
1; P<0.05).  The effect of HCTZ was fully reversed upon drug 
washout with solvent-containing bath solution, demonstrat-
ing that 10 µmol/L HCTZ is able to activate BK channels in 
human VSMCs.
HCTZ failed to modulate BK channel activity in the absence of 
cell integrity
To determine whether the HCTZ-induced increased ionic BK 
current in HUASMCs was due  to direct drug action on the BK 
channel proteins or required cell integrity and intact signaling, 
we next examined the effect of HCTZ on BK currents at a sin-
gle channel resolution using the IO configuration of the patch-
clamp technique.  Thus, we recorded steady-state channel 
activity (NPo; see methods) at a constant voltage (+40 mV) in 
the presence or absence of 10 µmol/L HCTZ.  Interestingly, in 
this cell-free condition, HCTZ failed to modulate channel func-
tion: neither unitary current amplitude (Figure 2B, P>0.05) nor 
NPo was modified by HCTZ concentrations that increased the 
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macroscopic BK current (Figure 2C, P>0.05).  Collectively, the 
results shown in Figures 1 and 2 indicate that HCTZ requires 
cell integrity to increase BK currents.
HCTZ-mediated activation of recombinant BK channels in a 
mammalian heterologous system requires cell integrity and the 
presence of BK regulatory β1-subunits 
The results shown above demonstrate that HCTZ is able  to 
activate BK channels in HUASMCs.  In contrast, this drug 
failed to activate BK channels in skeletal muscle and HEK cells 
expressing only the α-subunit[36, 37].  Thus, since endogenous 
β1-subunits are highly expressed in vascular smooth muscle 
cells but not in skeletal muscle cells or HEK cells, we hypothe-
sized that the β1-subunit was necessary for HCTZ-induced BK 
channel activation in HUASMCs[21, 25, 29].  To test this hypothe-
sis, we expressed the channel α-subunit in HEK293T cells with 
or without the β1-subunit and examined the effect of HCTZ 
on these cells using the WCR configuration.  Consistent with 
our hypothesis, HCTZ failed to modulate BK channel activity 
in the absence of auxiliary subunits (Figure 3, P>0.05).  In con-
trast, HCTZ significantly increased the ionic current mediated 
by α+β1 heteromeric channels after 10–15 min of application 
(Figure 4A, B; P<0.05).
Next, we studied the HCTZ-induced BK activation in the 
Figure 1.  Hydrochlorothiazide (HCTZ) increases the large-conductance voltage- and Ca2+-activated K+ (BK) channel component of whole-cell (WC) K+ 
currents in human umbilical artery smooth muscle cells (HUASMCs).  (A) Superimposed representative recordings of WC currents of HUASMCs (recorded 
in 5 mmol/L 4-aminopyridine) obtained by applying 10 mV voltage steps from -70 mV to +70 mV from a holding potential of -50 mV in control condi-
tions, after 7 min of 10 µmol/L HCTZ perfusion and after washout.  (B) Mean current density vs voltage (I/Cm-V) curves, corresponding to the control 
conditions and after 7 min of 10 µmol/L HCTZ perfusion obtained in the same conditions as in a) (n=6 cells from 3 umbilical cord donors).  The symbol 
* indicates statistically significant difference from control (paired t test, P<0.05).
Figure 2.  HCTZ failed to activate BK channel in inside-out (IO) configuration in HUASMCs.  (A) Representative recording of BK channel current obtained 
at single channel resolution in an IO configuration at 40 mV in absence or presence of 10 µmol/L HCTZ.  The closed level is indicated as “c”.  (B and C) 
Mean current amplitude (B) and steady state activity (NPo) values (C) of BK channels recorded as shown in A) in control conditions and with 10 µmol/L 
HCTZ (n=7 patches from 3 umbilical cord donors).  No statistically significant differences were observed (paired t test, P>0.05).
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heterologous system in more detail.  Thus, the effect of the 
diuretic on the whole-cell BK current resulting from α+β1 
expression was examined at 10, 30, 100 and 300 µmol/L. 
HCTZ induced a left-shift in the I-V curves (Figure 4A, B; 
P<0.05).  Consistently, higher increases in fractional activity 
were observed at less depolarized voltages, at which the basal 
open probability is lower (Figure 4 C).  Additionally, we plot-
ted the concentration-response curve at all membrane poten-
tials where the HCTZ-induced current increase was statisti-
cally significant (from +20 to +90 mV) and fitted these data to a 
Hill equation.  The current-enhancing effect of HCTZ presents 
an EC50 of 28.4 µmol/L (95%CI: 10.4 - 77.7 µmol/L) measured 
at +40 mV, rendering a pD2=4.546±0.211 (n: 5–8, Figure 4 D). 
Moreover, both pD2 and the Hill slope of HCTZ activation 
were voltage independent (Figures 4E and 4F, respectively, 
P>0.05).  These results showed that HCTZ increased the BK 
current when the channel emulates the basic composition of 
this channel in HUASMCs[32].  
The results, showed above on native HUASMCs demon-
strated that cellular integrity is essential for HCTZ-induced 
BK channel activation (Figure 2).  To validate these findings, 
we determined whether cellular integrity is required for the 
HCTZ-induced activation of recombinant BK channels con-
taining the β1-subunit in a mammalian expression system. 
First, we obtained macroscopic currents (in the IO configura-
tion) evoked from β1-containing BK channels in the presence 
or absence of HCTZ in HEK cells.  HCTZ had no effect on BK 
current at any examined concentration (10, 30 and 100 µmol/L) 
(Figure 5 C, P>0.05).  Figure 5 B shows the I-V relationships 
obtained for each condition.  The negative results from the 
IO configuration could indicate that this diuretic requires cell 
integrity to activate the BK channel.  However, considering the 
poor lipophilicity of HCTZ (log P: -0.07), these results could 
also indicate that the region responsible for BK channel acti-
vation is located on the extracellular side of the channel.  To 
clarify this issue, we examined the effect of HCTZ on recombi-
nant BK channels containing the β1-subunit in HEK293T cells 
at single channel resolution using the cell-attached (CA) con-
figuration.  A concentration of 100 µmol/L HCTZ increased 
the steady state BK channel open probability at a 40 mV 
membrane potential.  Figure 5D shows a typical stability plot 
of channel activation, where the open probability (expressed 
as NPo) was calculated every 30 s and plotted as a function 
of the recording time.  HCTZ slowly increased the NPo of the 
BK channel, reaching maximal steady state activation after 
approximately 15 min of HCTZ perfusion.  Typical recordings 
of BK channel activity before and after diuretic perfusion are 
included in Figure 5D.  HCTZ induced a significant 4.72±1.24-
fold increase in the NPo values (Figure 5E, P<0.05, n=3).  This 
change in channel activity recorded in the CA configuration 
Figure 3.  HCTZ failed to modulate BK channel activity in the absence of regulatory β-subunits in HEK293T cells.  (A) Superimposed representative WCR 
currents of BK channels expressed in HEK293T cells without the β1-subunit, before (left) and after 15 min of 100 µmol/L HCTZ perfusion (right).  The 
currents were elicited in response to 10 mV voltage steps from -60 mV to +90 mV from a holding potential of -50 mV.  (B) I-V curves corresponding to 
the control conditions and 15 min of 100 µmol/L HCTZ perfusion.  The BK channel currents were normalized to the ones elicited by the +90 mV voltage 
step under control conditions.  (C) Fractional increases in current size at +40 mV induced by 100 and 300 µmol/L HCTZ.  No statistically significant dif-
ferences were observed (ANOVA, Ranks test, P>0.05).
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Figure 4.  HCTZ activates recombinant BK channels expressed with regulatory β1-subunits in HEK293T cells in a concentration-dependent manner.  Su-
perimposed representative WCR currents of BK channels expressed in HEK293T cells with the β1-subunit, before (left) and after 15 min of 10 (A) and 
100 µmol/L (B) HCTZ perfusion (middle).  The currents were elicited in response to 10 mV voltage steps from -60 mV to +90 mV from a holding poten-
tial of -50 mV.  Mean current vs voltage (I-V) curves corresponding to the control conditions and 15 min of 10 and 100 µmol/L HCTZ perfusion (right). 
The BK channel currents were normalized to the ones elicited by the +90 mV voltage step under control conditions.  The symbol * indicates statistically 
significant difference from control (paired t test, P<0.05).  (C) Fractional increases in current size at different voltages (n=6–8) induced by 10 and 100 
µmol/L HCTZ.  (D) Concentration-dependence of HCTZ-induced BK channel activation.  Currents were measured at +40 mV and a single concentration 
of HCTZ shown was tested in each cell.  Data points were fitted by a Hill function (solid line).  Half-maximal effective concentration (EC50): 28.4 µmol/L 
(95%CI: 10.4–77.7 µmol/L), Hill slope: 1.6 (95% CI: 0.586 to 2.781).  (E, F) Voltage-dependence of the EC50, expressed as pD2 (±SEM), and Hill Slope 
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Figure 5.  HCTZ requires cell integrity to activate recombinant BK channels expressed with the β1-subunit in HEK293T cells.  (A) Superimposed repre-
sentative cell-free IO currents of BK channels expressed in HEK293T cells with the β1-subunit, before (left) and after 15 min of 100 µmol/L HCTZ perfu-
sion (right).  The currents were elicited in response to 20 mV voltage steps from -90 mV to +130 mV from a holding potential of 0 mV.  (B) I-V curves cor-
responding to the control conditions and 15 min of 100 µmol/L HCTZ perfusion recorded as A.  The BK channel currents were normalized to the ones 
elicited by the +130 mV voltage step under control conditions.  (C) Fractional increases in current size at +90 mV induced by 10, 30 and 100 µmol/L 
HCTZ.  No statistically significant differences were observed (ANOVA, Ranks test, P>0.05).  (D) Temporal course of 100 µmol/L HCTZ effect on BK chan-
nels expressed in HEK293T cells with the β1-subunit recorded in the Cell-Attached configuration at 40 mV.  Single-channel activity was expressed as 
NPo, which values were calculated every 30 s and plotted as a function of recording time.  The inset corresponds to representative traces of BK channel 
activity in control condition and during 100 µmol/L HCTZ perfusion.  (E) Mean changes in activity values (NPo) of BK channels recorded as described in 
Figure 5D in control conditions and with 100 µmol/L HCTZ.  The symbol * indicates statistically significant difference from control (paired t test, P<0.05).
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can only occur through indirect mechanisms or the direct 
activity of membrane permeable drugs that can access the ion 
channel present in the patch only after crossing the plasma 
membrane from the bath solution to the cytoplasmic milieu. 
The results in the IO configuration enabled the rejection of the 
latter mechanism, confirming the cell integrity requirement for 
BK channel activation by HCTZ.  
Discussion
The present study represents the first use of patch-clamp 
electrophysiology to evaluate the effect of HCTZ, a thiazide 
diuretic, on BK currents in a VSMC.  Evaluating the effect of 
HCTZ on whole-cell BK currents in both native and heterolo-
gous systems demonstrated that 1) HCTZ activates the BK 
channel present in human VSMCs, confirming this channel as 
a probable target for the diuretic’s vasodilator effect; 2) The 
presence of the β1 accessory subunit is necessary for HCTZ to 
activate BK channels; and 3) HCTZ-induced BK channel acti-
vation requires cellular integrity.  
The reduction in peripheral vascular resistance is a common 
property of thiazide-like diuretics that is not related to the 
NCC blockage[2].  However, evidence suggests that different 
thiazides do not share the same mechanisms for the induc-
tion of vasodilation[5, 8].  In particular, Calder et al previously 
proposed the HCTZ-induced BK channel activation[5, 8], as a 
probable mechanism to explain the dilation of guinea pig mes-
enteric and human subcutaneous arteries through the in vitro 
application of HCTZ.  Indeed, in the guinea pig model, the 
relaxation effect of this diuretic was independent of the pres-
ence or absence of the endothelium[8].  Additionally, HCTZ 
induced Rb86 efflux[12] and vessel relaxation, both actions being 
largely blocked by the selective BK channel blocker iberio-
toxin[8].  Subsequently, Pickkers et al[7], also studying the mes-
enteric guinea pig artery, demonstrated that HCTZ reduced 
the increase in intracellular Ca2+ concentration evoked by 
norepinephrine without affecting the Ca2+ release from intra-
cellular Ca2+ stores.  These authors speculated that HCTZ acti-
vates BK channels, and this activation, acting as a hyperpolar-
izing mechanism, reduces the Ca2+ influx through the VOCC. 
Collectively, these previous studies have suggested that BK 
channel activation contributes to HCTZ-induced vasodilation. 
However, whether HCTZ increases the smooth muscle BK 
potassium current through direct or indirect interactions with 
this channel protein has remained unknown.  Addressing this 
dichotomy acquired particular relevance in light of studies 
showing that BK channel activity could be enhanced by vaso-
dilator substances acting directly on the channel protein[30, 43] 
and via intracellular signaling and shuttling of BK proteins 
between intracellular organelles and the plasmalemma[16]. 
In the present study, using HUASMCs, we propose that 
HCTZ activates the BK channel not through a direct interac-
tion between the diuretic and the channel protein but rather 
through an indirect mechanism that requires cell integrity. 
This idea is sustained by the fact that BK current enhance-
ment was observed only in whole-cell (Figures 1 and 4) and 
cell-attached configurations (Figure 5D), while in the cell-free 
inside-out configuration (Figures 2 and 5A), neither the uni-
tary channel conductance nor its open probability were modi-
fied by HCTZ.  The similar outcomes between studies using 
vascular smooth muscle and HEK cells strongly suggests that 
the indirect mediator(s) of HCTZ-thiazide interaction on BK 
channels is conserved between two different cell types.  
Several mechanisms can be proposed to explain how 
HCTZ indirectly alters channel activity.  There is a growing 
list of interacting proteins and mediators associated with the 
C-terminus of the BK α-subunit.  Moreover, these molecules 
depend on each particular cellular environment, α-subunit 
splicing variants, and co-expression with auxiliary subunits[44]. 
This list can include different intracellular ions (such as Mg2+, 
Ca2+ and H+); protein kinases (such as PKA, PKC, PKG, PyK2 
and FAK); intracellular mediators (such as GMPc, PIP2 and 
arachidonic acid); receptors that regulate channel activity 
independent of downstream pathways (such as β2-adrenergic 
and thromboxane A2 receptor); and structural cell proteins (eg, 
caveolin and actin)[44].  It has been hypothesized that HCTZ-
induced increases in intracellular pH in VSMCs (via carbonic 
anhydrase inhibition) is responsible for BK channel activa-
tion[45].  This hypothesis contrasts with the low antihyperten-
sive efficacy of specific carbonic anhydrase inhibitors[1], such 
as acetozolamide.  The present data also contrast with the “pH 
hypothesis”: we demonstrated that HCTZ action is conserved 
under conditions in which changes in pHi in the electrode 
solution (ie, WCR configuration) were precluded by strong 
buffering.  Thus, it is highly likely that the mediators of HCTZ 
BK channel activation in HUASMCs are membrane bound (eg, 
PKC translocation and BK subunit shuttling).
The experiments on BK channel expressed in HEK293T cells 
further clarify the mechanism implicated in channel activation 
by HCTZ.  In the whole cell configuration, HCTZ produces 
a concentration-dependent BK current enhancement with an 
EC50 value of 28 µmol/L (Figure 4D).  Interestingly, this con-
centration was similar to that measured by Calder et al[8] in 
ex vivo experiments and the concentration used in previous 
studies[5-7, 12, 45].  Additionally, the EC50 and Hill slope values 
were both voltage-independent (Figures 4E and 4F), indicating 
that putative intracellular mediators involved in the indirect 
effect of HCTZ, are insensitive to the membrane voltage field 
and likely membrane associated (similar to observations in 
HUASMCs, and the effect is lost in IO patches).
The physiological and pharmacological modulation of the 
BK channel, including by HCTZ, is variable among differ-
ent cell types[5, 19].  The differential expression of the auxiliary 
β-subunits can explain, in part, this variability, as these sub-
units have been reported to interact with the α-subunit, pro-
moting or decreasing the effects of endogenous or exogenous 
substances on channel activity[19, 30, 31, 43].  Moreover, the expres-
sion of these four subtypes is different among tissues[21, 46, 47] 
and even among different arteries from the same species[48]. 
Thus, β-subunits would be key structures to obtain a tissue-
selective pharmacological modulation of the BK channel[19].  In 
the case of HCTZ, we demonstrated that the presence of the 
β1-subunit, which is primarily expressed in smooth muscle 
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cells, is a requirement for BK channel activation (Figures 3 and 
4).  This result also explains why Tricarico et al did not observe 
BK channel current enhancement by HCTZ in skeletal muscle 
cells[37], where the channel is expressed without any β-subunit, 
and in HEK cells transfected only with the α-subunit[36].  Col-
lectively, the present results, which include both the complex-
ity of the native cells and the simplicity of the heterologous 
system, demonstrated that the activation of the BK channels by 
HCTZ is effective in human vascular cells, likely involving an 
intracellular factor, and shows selectivity for the α-β1-complex 
without affecting the channel formed only by four α-subunits.  
Notably, the HCTZ effect depends on the species employed 
for the experimental procedures[5].  Particularly, in human 
vasculature, the activation of a K+ channel by thiazide-like 
diuretics was supported by previous in vivo and ex vivo experi-
ments.  HCTZ relaxes human subcutaneous and internal 
mammary arteries, and this effect is blocked by charybdo-
toxin, which inhibits BK and intermediate Ca2+-activated 
channel[5, 6].  Moreover, tetraethylammonium (a nonselective 
K+ channels blocker) avoids the in vivo vasodilator effect of 
HCTZ in the human forearm artery[4].  Here, we demonstrated 
BK channel activation induced by HCTZ in human umbilical 
artery smooth muscle cells.  Taken together, these results sug-
gest that HCTZ-induced BK activation is a relevant process in 
human vasculature and support the idea that this activation 
is likely involved in the vasorelaxant effect of this commonly 
used antihypertensive drug.
In conclusion, we propose that BK channel activation by 
HCTZ could contribute to its vasodilator effects, an action 
resulting from HCTZ acting on the SMC itself, while requiring 
cell integrity but not direct binding to the BK channel proteins. 
Thus, the present experimental approach represents signifi-
cant progress in determining the molecular target or signal-
ing pathway responsible for HCTZ-induced SMC relaxation. 
Moreover, we speculate that BK channel activation in vascular 
SMCs may be, at least partially, responsible for the efficacy of 
hypertension treatment with thiazide diuretics.  Finally, we 
provide additional evidence for the growing acceptance of using 
the BK channel as a target for hypertension treatment, focusing 
on the β1-subunit as the key to obtaining selectivity in VSMCs.
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